Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
2.250
+0.220 (10.84%)
At close: Nov 20, 2026, 4:00 PM EST
2.340
+0.090 (4.00%)
After-hours: Nov 20, 2026, 7:58 PM EST
Evaxion Market Cap
Evaxion has a market cap or net worth of $20.75 million as of November 20, 2026. It is the 36,105th most valuable company in the world and the 5,070th biggest in the United States. Its market cap has decreased by 49.01% in one year.
Market Cap
20.75M
Enterprise Value
13.86M
1-Year Change
-49.01%
Global Rank
Country Rank
#5,070 United States
Category
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $20.75M, a decrease of -89.19%. That is a compound annual growth rate of -31.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 20.75M | -47.84% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 23.04M |
| ABVC BioPharma | 22.74M |
| Polyrizon | 22.61M |
| GridAI Technologies | 22.38M |
| CervoMed | 22.09M |
| Metagenomi Therapeutics | 21.36M |
| CEL-SCI | 21.28M |
| Aardvark Therapeutics | 20.19M |